Skip to main content
. 2008 Jul 29;99(3):481–487. doi: 10.1038/sj.bjc.6604523

Figure 2.

Figure 2

Thymidine kinase (TK) activities in MDA MB231 breast cancer cells (A) without, and with addition of the TK-2 inhibitors (B) dCTP and (C) KIN52. Cells were incubated with IC50 concentrations of 5-fluorouracil (Inline graphic), doxorubicin (Inline graphic) and paclitaxel (▪), and compared with untreated cells (□).